Leave Your Message

GMP-TL778 Anti-Human CD137 mAb from China Suppliers - T Cell Proliferation & Cytokine Secretion Factory

Introducing the GMP-TL778, a high-quality product manufactured in China. This model stands out for its exceptional design and durability, making it a preferred choice among top suppliers in the industry. With a focus on excellence, our factory ensures that each unit meets stringent quality standards. Currently, the GMP-TL778 is in stock and ready for immediate shipment, providing you with reliable service and prompt delivery. Experience the best from China’s leading manufacturers and suppliers with the GMP-TL778.

    Introduction to 4-1BB (CD137)

    4-1BB, also known as CD137, is an inducible cell surface receptor and one member of the tumor necrosis factor receptor (TNFR) superfamily. CD137 is encoded by the tumor necrosis factor receptor superfamily member 9 (TNFRSF9) gene and is widely expressed on the surface of activated T cells and NK cells.

    Key Immune Pathway Mediator

    CD137 / CD137L mediate immune responses by transmitting activation, proliferation, or apoptotic signals between immune cells.

    The Role of CD137L (Ligand)

    Its ligand, CD137L, is also a TNFSF member and functions as an inducible costimulatory receptor. It is expressed by a wide range of immune cells, including:

    • Activated CD4+ and CD8+ T cells (especially on CD8+ T cells)
    • NKT and NK cells
    • Dendritic Cells (DC) and macrophages
    • Eosinophils, neutrophils, and mast cells

    Immune Activation

    The activation of CD137 can stimulate NK cell and T cell proliferation and generate anti-tumor activity, which induces durable memory responses.

    Intracellular Signaling

    4-1BB mAb can activate 4-1BB to recruit TNFR-related factors TRAF1 and TRAF2. These factors form a heterotrimer, strengthening signal transduction through c-Jun N-terminal kinase (JNK) or extracellular signal-regulated kinase (ERK) pathways.

    This resulting heterotrimer can stimulate the proliferation of T cells and antigen-presenting cells, improve the anti-tumor immune response of the body, and secrete cytokines through the transcription of NF-κB.

    Frequently Asked Questions

    What is 4-1BB (CD137)?
    4-1BB, also known as CD137, is an inducible cell surface receptor and a member of the tumor necrosis factor receptor (TNFR) superfamily. It is encoded by the TNFRSF9 gene.
    Where is CD137 expressed?
    CD137 is widely expressed on the surface of activated T cells and NK (Natural Killer) cells.
    Which cell types express the ligand CD137L?
    CD137L is expressed by activated CD4+ and CD8+ T cells (especially CD8+ T cells), NKT cells, NK cells, dendritic cells (DC), macrophages, eosinophils, neutrophils, and mast cells.
    What are the primary functions of the CD137 / CD137L interaction?
    They mediate immune responses by transmitting activation, proliferation, or apoptotic signals between immune cells. Activation of CD137 stimulates NK cell and T cell proliferation and generates anti-tumor activity with durable memory responses.
    How does 4-1BB mAb trigger downstream signaling?
    4-1BB mAb activates 4-1BB to recruit the TNFR-related factors TRAF1 and TRAF2. These factors form a heterotrimer that strengthens signal transduction through the c-Jun N-terminal kinase (JNK) or extracellular signal-regulated kinase (ERK) pathways.
    What is the ultimate outcome of the TRAF1/TRAF2 heterotrimer formation?
    It stimulates the proliferation of T cells and antigen-presenting cells, improves the body's anti-tumor immune response, and induces cytokine secretion through the transcription of NF-κB.